MarketInOut Stock Screener Log In | Sign Up

AEON Biopharma Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/30/2026
AEON Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization15.6 mln
Float23.78 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

1.82
Transformational upside

Relative Strength

96 / 100
Top performer

ROE

204
Extraordinary

ROA

-674
Deeply negative

Business Description

AEON Biopharma is a California-based medical company working to bring new treatments to patients suffering from serious and often overlooked conditions. Its main focus is a drug called prabotulinumtoxinA, a form of botulinum toxin being studied for conditions such as cervical dystonia, chronic migraine, gastroparesis, and post-traumatic stress disorder. The company operates through partnerships with Daewoong Pharmaceutical and Viatris to advance its clinical programs.

Key Fundamentals

EPS-4.39
ROE204
ROIC-474
ROA-674
EBITDA, mln-54.54
EV / EBITDA-0.53
EV / EBIT-0.53

Quote Details

Last 0.274
Change -0.02 (-6.8%)
Open 0.2844
Volume 774,171
Turnover 212,123
Average Volume 1,008,960

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price1.82
Short Ratio0.50
Short % of Float8.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 14.21% 96 / 100   
1 Month -5.52% 38 / 100   
2 Months 5.38% 83 / 100   
6 Months -69.21% 7 / 100   
1 Year -68.86% 12 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog